517 related articles for article (PubMed ID: 22584081)
21. Nonmelanoma skin cancer in inflammatory bowel disease: a review.
Long MD; Kappelman MD; Pipkin CA
Inflamm Bowel Dis; 2011 Jun; 17(6):1423-7. PubMed ID: 21053358
[TBL] [Abstract][Full Text] [Related]
22. Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study.
Setshedi M; Epstein D; Winter TA; Myer L; Watermeyer G; Hift R
J Gastroenterol Hepatol; 2012 Feb; 27(2):385-9. PubMed ID: 21793904
[TBL] [Abstract][Full Text] [Related]
23. Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.
Mamtani R; Clark AS; Scott FI; Brensinger CM; Boursi B; Chen L; Xie F; Yun H; Osterman MT; Curtis JR; Lewis JD
Arthritis Rheumatol; 2016 Oct; 68(10):2403-11. PubMed ID: 27159030
[TBL] [Abstract][Full Text] [Related]
24. Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma--challenges in management.
Lee J; Clarke K
Int J Colorectal Dis; 2015 Dec; 30(12):1595-602. PubMed ID: 26349591
[TBL] [Abstract][Full Text] [Related]
25. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
[TBL] [Abstract][Full Text] [Related]
26. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
[TBL] [Abstract][Full Text] [Related]
27. Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?
Garg SK; Loftus EV
Curr Opin Gastroenterol; 2016 Jul; 32(4):274-81. PubMed ID: 27152873
[TBL] [Abstract][Full Text] [Related]
28. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease.
Moran GW; Lim AW; Bailey JL; Dubeau MF; Leung Y; Devlin SM; Novak K; Kaplan GG; Iacucci M; Seow C; Martin L; Panaccione R; Ghosh S
Aliment Pharmacol Ther; 2013 Nov; 38(9):1002-24. PubMed ID: 24099467
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel disease treatment and non-melanoma skin cancer: a case report.
De Luca JF; Lee YS; Johnson D
Hawaii J Med Public Health; 2012 Nov; 71(11):324-5. PubMed ID: 23155491
[TBL] [Abstract][Full Text] [Related]
30. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
[TBL] [Abstract][Full Text] [Related]
31. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
[TBL] [Abstract][Full Text] [Related]
32. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma.
Nissen LHC; Pierik M; Derikx LAAP; de Jong E; Kievit W; van den Heuvel TRA; van Rosendael AR; Plasmeijer EI; Dewint P; Verhoeven RHA; Overbeek LIH; Nagtegaal ID; Hoentjen F; van der Meulen-de Jong AE
Inflamm Bowel Dis; 2017 Nov; 23(11):2018-2026. PubMed ID: 28837522
[TBL] [Abstract][Full Text] [Related]
34. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
35. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.
Kirchgesner J; Nyboe Andersen N; Carrat F; Jess T; Beaugerie L;
Gut; 2020 May; 69(5):852-858. PubMed ID: 31446428
[TBL] [Abstract][Full Text] [Related]
36. Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Diseases Receiving Treatment With Thiopurines.
Khan N; Lee H; Trivedi C; Kavani H; Medvedeva E; Xie D; Lewis JD; Yang YX
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2262-2268. PubMed ID: 30853615
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
[TBL] [Abstract][Full Text] [Related]
38. Incidence of Colorectal Cancer and Extracolonic Cancers in Veteran Patients With Inflammatory Bowel Disease.
Mosher CA; Brown GR; Weideman RA; Crook TW; Cipher DJ; Spechler SJ; Feagins LA
Inflamm Bowel Dis; 2018 Feb; 24(3):617-623. PubMed ID: 29390104
[TBL] [Abstract][Full Text] [Related]
39. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
Rungoe C; Basit S; Ranthe MF; Wohlfahrt J; Langholz E; Jess T
Gut; 2013 May; 62(5):689-94. PubMed ID: 22961677
[TBL] [Abstract][Full Text] [Related]
40. Risk of skin cancer in patients on chronic haemodialysis: a nationwide, population-based study in Taiwan.
Wang CC; Tang CH; Wang CY; Huang SY; Sue YM
Br J Dermatol; 2016 Dec; 175(6):1175-1182. PubMed ID: 27273242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
